Status:
RECRUITING
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
Lead Sponsor:
Seoul National University
Collaborating Sponsors:
Hanyang University
Conditions:
Complex Regional Pain Syndromes
Eligibility:
All Genders
19-80 years
Brief Summary
This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).
Detailed Description
Participants who meet the diagnostic criteria for CRPS, aged 19\~80 years, and agree to participate in this study will undergo a 4mm-sized skin punch biopsy in the involved limb, as well as the contra...
Eligibility Criteria
Inclusion
- Meets the Budapest diagnostic criteria
- Consents to participation in this study
- Aged between 19 and 80 years old
- Symptoms and/or signs of sensory, vasomotor, and sudomotor changes
Exclusion
- Who do not agree to participate in this study
- Who has contraindications for skin punch biopsy (e.g. thrombocytopenia, taking anticoagulant drugs)
Key Trial Info
Start Date :
July 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05986461
Start Date
July 18 2023
End Date
December 31 2024
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea